News + Filings Transactions
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
|
|
Niihara Yutaka
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 01/17/2023 |
4
| Niihara Yutaka (Chairman and CEO) has filed a Form 4 on Emmaus Life Sciences, Inc.|
Txns:
| Granted 7,500,000 warrants
@ $4.5, valued at
$33.8M
|
|
| 12/01/2022 |
4
| Niihara Yutaka (Chairman and CEO) has filed a Form 4 on Emmaus Life Sciences, Inc.|
Txns:
| Bought 2,500 shares
@ $0.45, valued at
$1.1k
Bought 7,500 shares
@ $0.45, valued at
$3.4k
Bought 5,000 shares
@ $0.35, valued at
$1.8k
Bought 14,700 shares
@ $0.38, valued at
$5.6k
Bought 22,900 shares
@ $0.41, valued at
$9.4k
|
|
| 11/09/2022 |
SC 13D/A
| Niihara Yutaka reports a 26.4% stake in Emmaus Life Sciences, Inc. |
| 11/03/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 10/24/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 10/19/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 10/17/2022 |
4
| Niihara Yutaka (Chairman and CEO) has filed a Form 4 on Emmaus Life Sciences, Inc.|
Txns:
| Bought 62,500 shares
@ $0.18, valued at
$11.3k
Bought 35,000 shares
@ $0.17, valued at
$6k
|
|
| 10/13/2022 |
4
| Niihara Yutaka (Chairman and CEO) has filed a Form 4 on Emmaus Life Sciences, Inc.|
Txns:
| Bought 5,000 shares
@ $0.09, valued at
$450
Bought 160,000 shares
@ $0.08, valued at
$12.8k
|
|
| 10/12/2022 |
4
| Niihara Yutaka (Chairman and CEO) has filed a Form 4 on Emmaus Life Sciences, Inc.|
Txns:
| Bought 6,000 shares
@ $0.2, valued at
$1.2k
Bought 5,000 shares
@ $0.2, valued at
$1k
Bought 10,000 shares
@ $0.2, valued at
$2k
Bought 5,000 shares
@ $0.16, valued at
$800
Bought 10,000 shares
@ $0.15, valued at
$1.5k
Bought 5,000 shares
@ $0.15, valued at
$750
Bought 4,000 shares
@ $0.13, valued at
$520
Bought 10,000 shares
@ $0.09, valued at
$900
Bought 130,000 shares
@ $0.09, valued at
$11.7k
|
|
| 06/02/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 05/19/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 03/02/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/28/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/23/2022 |
4
| Niihara Yutaka (Chairman and CEO) has filed a Form 4 on Emmaus Life Sciences, Inc.|
Txns:
| Bought 1,500 shares
@ $1.43, valued at
$2.1k
Bought 17,800 shares
@ $1.44, valued at
$25.6k
|
|
| 02/18/2022 |
4
| Niihara Yutaka (Chairman and CEO) has filed a Form 4 on Emmaus Life Sciences, Inc.|
Txns:
| Bought 1,000 shares
@ $1.47, valued at
$1.5k
Bought 6,500 shares
@ $1.43, valued at
$9.3k
|
|
| 02/16/2022 |
SC 13D/A
| Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend] |
| 02/16/2022 |
4
| Niihara Yutaka (Chairman and CEO) has filed a Form 4 on Emmaus Life Sciences, Inc.|
Txns:
| Bought 6,000 shares
@ $1.45, valued at
$8.7k
Bought 6,000 shares
@ $1.45, valued at
$8.7k
|
|
| 02/11/2022 |
4
| Niihara Yutaka (Chairman and CEO) has filed a Form 4 on Emmaus Life Sciences, Inc.|
Txns:
| Bought 23,500 shares
@ $1.45, valued at
$34.1k
Bought 3,000 shares
@ $1.45, valued at
$4.4k
Bought 4,000 shares
@ $1.49, valued at
$6k
|
|
| 02/09/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/07/2022 |
4
| Niihara Yutaka (Chairman and CEO) has filed a Form 4 on Emmaus Life Sciences, Inc.|
Txns:
| Bought 6,250 shares
@ $1.4, valued at
$8.8k
Bought 7,000 shares
@ $1.43, valued at
$10k
|
|
| 01/03/2022 |
4
| Niihara Yutaka (Chairman and CEO) has filed a Form 4 on Emmaus Life Sciences, Inc.|
Txns:
| Bought 1,000 shares
@ $1.6, valued at
$1.6k
Bought 2,700 shares
@ $1.57, valued at
$4.2k
Bought 6,800 shares
@ $1.56, valued at
$10.6k
Bought 7,000 shares
@ $1.58, valued at
$11.1k
|
|
| 12/28/2021 |
4
| Niihara Yutaka (Chairman and CEO) has filed a Form 4 on Emmaus Life Sciences, Inc.|
Txns:
| Bought 5,000 shares
@ $1.48, valued at
$7.4k
Bought 1,500 shares
@ $1.5, valued at
$2.3k
Bought 1,200 shares
@ $1.48, valued at
$1.8k
|
|
| 12/22/2021 |
4
| Niihara Yutaka (Chairman and CEO) has filed a Form 4 on Emmaus Life Sciences, Inc.|
Txns:
| Bought 2,750 shares
@ $1.49, valued at
$4.1k
Bought 3,000 shares
@ $1.51, valued at
$4.5k
Bought 4,900 shares
@ $1.49, valued at
$7.3k
|
|
| 12/17/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 12/10/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 12/06/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 12/02/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 12/01/2021 |
SC 13D/A
| Niihara Yutaka reports a 26.3% stake in Emmaus Life Sciences, Inc. |
| 11/30/2021 |
4
| Niihara Yutaka (Chairman and CEO) has filed a Form 4 on Emmaus Life Sciences, Inc.|
Txns:
| Bought 56,009 shares
@ $1.41, valued at
$79k
Bought 16,000 shares
@ $1.45, valued at
$23.2k
|
|
| 11/26/2021 |
4
| Niihara Yutaka (Chairman and CEO) has filed a Form 4 on Emmaus Life Sciences, Inc.|
Txns:
| Bought 7,000 shares
@ $1.35, valued at
$9.5k
Bought 19,300 shares
@ $1.34, valued at
$25.9k
|
|
| 11/23/2021 |
4
| Niihara Yutaka (Chairman and CEO) has filed a Form 4 on Emmaus Life Sciences, Inc.|
Txns:
| Bought 15,000 shares
@ $1.39, valued at
$20.9k
Bought 12,000 shares
@ $1.44, valued at
$17.3k
|
|
| 11/19/2021 |
4
| Niihara Yutaka (Chairman and CEO) has filed a Form 4 on Emmaus Life Sciences, Inc.|
Txns:
| Bought 2,000 shares
@ $1.25, valued at
$2.5k
Bought 5,000 shares
@ $1.28, valued at
$6.4k
Bought 13,000 shares
@ $1.29, valued at
$16.8k
Bought 13,000 shares
@ $1.28, valued at
$16.6k
|
|
| 10/22/2021 |
4
| Niihara Yutaka (Chairman and CEO) has filed a Form 4 on Emmaus Life Sciences, Inc.|
Txns:
| Bought 1,000 shares
@ $1.57, valued at
$1.6k
|
|
| 10/07/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
|
|
|